185 related articles for article (PubMed ID: 36294824)
1. Patient-Specific Mathematical Model of the Clear Cell Renal Cell Carcinoma Microenvironment.
Sofia D; Mohammad Mirzaei N; Shahriyari L
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294824
[TBL] [Abstract][Full Text] [Related]
2. A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.
Mohammad Mirzaei N; Su S; Sofia D; Hegarty M; Abdel-Rahman MH; Asadpoure A; Cebulla CM; Chang YH; Hao W; Jackson PR; Lee AV; Stover DG; Tatarova Z; Zervantonakis IK; Shahriyari L
J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683171
[TBL] [Abstract][Full Text] [Related]
3. Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma.
Pan H; Lu W; Zhang M; Liu C
Front Oncol; 2023; 13():1131191. PubMed ID: 37182129
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
[TBL] [Abstract][Full Text] [Related]
5. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.
Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R
Cells; 2022 Dec; 12(1):. PubMed ID: 36611966
[TBL] [Abstract][Full Text] [Related]
6. Bio-Mechanical Model of Osteosarcoma Tumor Microenvironment: A Porous Media Approach.
Hu Y; Mohammad Mirzaei N; Shahriyari L
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551627
[TBL] [Abstract][Full Text] [Related]
7. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
Bao W; Han Q; Guan X; Wang Z; Gu M
Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
9. CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma.
Gong Q; Guo Z; Sun W; Du X; Jiang Y; Liu F
BMC Cancer; 2022 Nov; 22(1):1184. PubMed ID: 36397015
[TBL] [Abstract][Full Text] [Related]
10. Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma.
Li CS; Lu ZZ; Fang DL; Zhou WJ; Wei J
Transl Androl Urol; 2021 Jun; 10(6):2478-2492. PubMed ID: 34295734
[TBL] [Abstract][Full Text] [Related]
11. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
[No Abstract] [Full Text] [Related]
13. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma.
Jiang Y; Gou X; Wei Z; Tan J; Yu H; Zhou X; Li X
Cancer Cell Int; 2020; 20():166. PubMed ID: 32435157
[TBL] [Abstract][Full Text] [Related]
14. CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma.
Yang L; Liu Y; Zhang B; Yu M; Huang F; Zeng J; Lu Y; Yang C
Dis Markers; 2023; 2023():3606362. PubMed ID: 36712923
[TBL] [Abstract][Full Text] [Related]
15. Predicting Efficacy of 5-Fluorouracil Therapy via a Mathematical Model with Fuzzy Uncertain Parameters.
Shafiekhani S; Jafari AH; Jafarzadeh L; Sadeghi V; Gheibi N
J Med Signals Sens; 2022; 12(3):202-218. PubMed ID: 36120402
[TBL] [Abstract][Full Text] [Related]
16. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
17. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
20. A novel inflammation-associated prognostic signature for clear cell renal cell carcinoma.
Liu G; Xiong D; Che Z; Chen H; Jin W
Oncol Lett; 2022 Sep; 24(3):307. PubMed ID: 35949606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
